Lung Cancer Screening and Prevention Act of 2025
- house
- senate
- president
Last progress February 18, 2025 (9 months ago)
Introduced on February 18, 2025 by Vernon G. Buchanan
Sponsors (8)
House Votes
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Senate Votes
Presidential Signature
AI Summary
This bill lets Medicare cover more types of lung cancer screening tests. If the Food and Drug Administration has cleared or approved a test, Medicare could pay for it—even if the U.S. Preventive Services Task Force has not recommended it yet. The Centers for Medicare & Medicaid Services would set rules on coverage and payment limits for these tests.
The Secretary of Health and Human Services could decide who qualifies and how often people can get these screenings, after consulting with medical groups. These changes would start as soon as the bill becomes law and would apply to Medicare Part B preventive services.
- Who is affected: People with Medicare who are appropriate for lung cancer screening (as decided by the Secretary)
- What changes: Medicare can cover additional FDA-cleared or -approved lung cancer screening tests; CMS sets how often and how much is paid
- When: Takes effect upon becoming law, for Medicare Part B preventive services